<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sys-h" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sys-h</book-part-id>
      <title-group>
        <title>Hyalinosis, Inherited Systemic</title>
        <alt-title alt-title-type="alt-title">Synonym: Hyaline Fibromatosis Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shieh</surname>
            <given-names>Joseph TC</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Division of Medical Genetics<break/>Department of Pediatrics<break/>Institute for Human Genetics<break/>University of California San Francisco<break/>San Francisco, California</aff>
          <email>shiehj2@humgen.ucsf.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hoyme</surname>
            <given-names>H Eugene</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Pediatrics<break/>Sanford School of Medicine<break/>University of South Dakota<break/>Sanford Children's Hospital<break/>Sioux Falls, South Dakota</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Arbour</surname>
            <given-names>Laura T</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Medical Genetics<break/>Island Medical Program<break/>University of British Columbia<break/>Victoria, BC, Canada</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2008-02-27" date-type="created">
          <day>27</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date iso-8601-date="2013-04-11" date-type="updated">
          <day>11</day>
          <month>4</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="hgps" document-type="chapter">Hutchinson-Gilford Progeria Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="hyperek" document-type="chapter">Hyperekplexia</related-object>
      <abstract id="sys-h.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Inherited systemic hyalinosis is characterized by hyaline deposits in the papillary dermis and other tissues. It typically presents at birth or in infancy with severe pain with movement, progressive joint contractures, and often with severe motor disability, thickened skin, and hyperpigmented macules/patches over bony prominences of the joints. Gingival hypertrophy, skin nodules, pearly papules of the face and neck, and perianal masses are common. Complications of protein-losing enteropathy and failure to thrive can be life threatening. Cognitive development is normal. Many children with the severe form (previously called infantile systemic hyalinosis) die in early childhood; some with a milder phenotype (previously called juvenile hyaline fibromatosis) survive into adulthood.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of inherited systemic hyalinosis is based on clinical findings or results of genetic testing. Skin biopsy may reveal hyaline material accumulation in the dermis or nondiagnostic findings; intestinal biopsy may demonstrate villous atrophy and lymphangiectasia. Skeletal x-rays may reveal osteopenia, periosteal reaction, and lucent lesions. <italic toggle="yes">ANTXR2</italic> is the only gene in which mutation is known to cause inherited systemic hyalinosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Nonsteroidal anti-inflammatory drugs (NSAIDs), opiates, and possibly gabapentin for pain; consultation with a pain management specialist as needed; physiotherapy for joint contractures can be considered although pain may be problematic; possible nasogastric tube or gastrostomy tube feeding under supervision of a gastroenterologist and nutritionist; nutrition tailored for the possibility of malabsorption or lymphangiectasia; hydration and albumin infusions for protein-losing enteropathy; infections are treated based on the site of infection and causative agent; lesions that obstruct the airway or interfere with feedings can be excised, but may recur.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Anesthesiologists need to be aware of potential difficulties with endotracheal intubation.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Inherited systemic hyalinosis is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. If the pathogenic variants in the family are known, prenatal testing for pregnancies at increased risk is possible through laboratories offering either testing for the gene of interest or custom testing.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sys-h.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sys-h.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Inherited systemic hyalinosis is characterized by hyaline deposits in the papillary dermis and other tissues associated with the following distinctive clinical findings presented in order of their specificity for clinical diagnosis:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Hyperpigmented skin over bony prominences.</bold> Characteristic purplish patches develop over the medial and lateral malleoli of the ankles, the metacarpophalangeal joints, spine, and elbows. The degree of hyperpigmentation varies depending on the baseline pigmentation of the skin [<xref ref-type="bibr" rid="sys-h.REF.arbour.2001">Arbour et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Progressive contractures.</bold> Affected individuals can present with congenital contractures. Some mothers report deficient fetal activity during the pregnancy of the affected infant, and many parents note decreased passive and/or active movement of the extremities of their child. Contractures are progressive, and extremities become fixed with the hips and knees flexed and the ankles dorsiflexed. The elbows exhibit flexion contractures, and the wrists are typically positioned in extension with flexion contractures of the proximal interphalangeal and distal interphalangeal joints. Some individuals demonstrate milder features.</p>
            </list-item>
            <list-item>
              <p><bold>Pain or excessive crying.</bold> Severe pain with passive movement in infancy or early childhood is characteristic. Pathogenesis is unclear.</p>
            </list-item>
            <list-item>
              <p><bold>Gingival thickening.</bold> Affected individuals develop masses in the gingiva, which enlarge over time.</p>
            </list-item>
            <list-item>
              <p><bold>Other skin manifestations.</bold> Skin nodules and white to pink pearly papules that are a few millimeters in size are common on the face and neck. Fleshy lesions may appear in the perianal region. These lesions appear to develop and become more numerous over time. The skin is firm to palpation and has been described as thickened.</p>
            </list-item>
            <list-item>
              <p><bold>Unusual facies.</bold> A depressed nasal bridge, variable ear malformations (large, simple or low-set ears, and preauricular skin tags), and a slightly coarse facial appearance may be present.</p>
            </list-item>
            <list-item>
              <p><bold>Failure to thrive.</bold> Postnatal-onset growth deficiency is common. Some children develop chronic diarrhea and protein-losing enteropathy.</p>
            </list-item>
          </list>
          <p>Note: Disease grading based on organ involvement has been reported [<xref ref-type="bibr" rid="sys-h.REF.nofal.2009.695">Nofal et al 2009</xref>, <xref ref-type="bibr" rid="sys-h.REF.denadai.2012.732">Denadai et al 2012</xref>].</p>
        </sec>
        <sec id="sys-h.Testing">
          <title>Testing</title>
          <p><bold>Skin biopsy.</bold> Light microscopy demonstrates hyaline material in the dermis.</p>
          <p>Note: This finding may not be evident in the early stages of the disease [<xref ref-type="bibr" rid="sys-h.REF.arbour.2001">Arbour et al 2001</xref>]. The hyaline material appears as an amorphous eosinophilic substance that is periodic acid-Schiff (PAS) positive. It is thought to contain glycoproteins and collagen. The spindle-shaped fibroblasts dispersed in abundant amounts of hyaline material render a "chondroid appearance."</p>
          <p>Electron microscopy demonstrates cells filled with fine, fibrillary material with an enlarged endoplasmic reticulum and Golgi apparatus.</p>
          <p><bold>Intestinal biopsy and imaging.</bold> Findings in biopsy specimens from individuals with prominent gastrointestinal symptoms include villous atrophy, edema, lymphangiectasia, and hyalinosis. Rapid transit time has been reported in real-time upper-gastrointestinal imaging studies.</p>
          <p><bold>Skeletal radiographs.</bold> Radiographic abnormalities include generalized osteopenia, periosteal reaction, and lucent lesions. These nonspecific findings may affect long bones as well as the axial skeleton and can support a clinical suspicion of inherited systemic hyalinosis.</p>
          <sec id="sys-h.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">ANTXR2</italic>, the capillary morphogenesis gene-2, is the only gene in which pathogenic variants are currently known to cause inherited systemic hyalinosis.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="sys-h.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Inherited Systemic Hyalinosis</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">ANTXR2</italic>
                    </td>
                    <td headers="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">90%&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Multiexon deletion or insertion</td>
                    <td headers="hd_h_sys-h.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="sys-h.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="sys-h" object-id="sys-h.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="sys-h.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="sys-h.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="sys-h.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="sys-h.TF.1.4">
                  <label>4. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="sys-h.TF.1.5">
                  <label>5. </label>
                  <p>Multiple pathogenic variants have been identified [<xref ref-type="bibr" rid="sys-h.REF.dowling.2003.957">Dowling et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.hanks.2003.791">Hanks et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.elkamah.2010.213">El-Kamah et al 2010</xref>, <xref ref-type="bibr" rid="sys-h.REF.denadai.2012.732">Denadai et al 2012</xref>] (see <xref ref-type="sec" rid="sys-h.Molecular_Genetics">Molecular Genetics</xref>).</p>
                </fn>
                <fn id="sys-h.TF.1.6">
                  <label>6. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="sys-h.TF.1.7">
                  <label>7. </label>
                  <p><xref ref-type="bibr" rid="sys-h.REF.shieh.2006.e1485">Shieh et al [2006]</xref>, <xref ref-type="bibr" rid="sys-h.REF.denadai.2012.732">Denadai et al [2012]</xref></p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="sys-h.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">ANTXR2</italic> should be pursued first.</p>
            </list-item>
            <list-item>
              <p>If no pathogenic variant is identified or if only a single heterozygous pathogenic variant is identified through sequence analysis, deletion/duplication analysis can be considered.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family. Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p>
        </sec>
      </sec>
      <sec id="sys-h.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sys-h.Clinical_Description">
          <title>Clinical Description</title>
          <p>Inherited systemic hyalinosis, named for the characteristic hyaline deposits in the papillary dermis and other tissues of affected individuals, exhibits a broad spectrum of clinical severity [<xref ref-type="bibr" rid="sys-h.REF.mancini.1999.18">Mancini et al 1999</xref>, <xref ref-type="bibr" rid="sys-h.REF.urbina.2004.154">Urbina et al 2004</xref>]. Severely affected children often succumb in the first years of life; this severe phenotype was originally termed infantile systemic hyalinosis. Milder forms of the disease were originally described as juvenile hyaline fibromatosis (JHF); however, it has become clear that both the severe and mild forms occur on a continuum of clinical findings [<xref ref-type="bibr" rid="sys-h.REF.rahman.2002.975">Rahman et al 2002</xref>, <xref ref-type="bibr" rid="sys-h.REF.dowling.2003.957">Dowling et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.hanks.2003.791">Hanks et al 2003</xref>]. Thus, the term inherited systemic hyalinosis encompasses the entire spectrum of disease.</p>
          <p>Inherited systemic hyalinosis presents at birth or in infancy with severe pain with movement, progressive joint contractures, skin that is firm to palpation, and characteristic hyperpigmented macules/patches over bony prominences of the joints, especially the ankles, wrists, and metacarpal-phalangeal joints [<xref ref-type="bibr" rid="sys-h.REF.stucki.2001.122">Stucki et al 2001</xref>].</p>
          <p>The degree of hyperpigmentation varies depending on the baseline pigmentation of the skin [<xref ref-type="bibr" rid="sys-h.REF.arbour.2001">Arbour et al 2001</xref>].</p>
          <p>Pearly papules develop on the head and neck. Skin nodules, papules, and fleshy lesions develop especially periorally and perianally.</p>
          <p>The gingivae are thickened and may reveal focal masses. Dental abnormalities include malpositioned teeth, curved dental roots, or other dental abnormalities.</p>
          <p>Cognitive function is preserved; however, cases of delayed development have been reported [<xref ref-type="bibr" rid="sys-h.REF.nischal.2004.125">Nischal et al 2004</xref>].</p>
          <p>Excessive diaphoresis is common.</p>
          <p>Hepatomegaly may be present.</p>
          <p>Susceptibility to fractures may be increased.</p>
          <p>Failure to thrive is associated with difficulty in feeding and severe intractable protein-losing diarrhea, likely accompanying hyalinosis of the intestine.</p>
          <p>Recurrent infections may develop.</p>
          <p>Individuals with severe disease succumb to infection or complications of protein-losing enteropathy.</p>
          <p>Some individuals demonstrate a milder phenotype (previously described as JHF), which may be of later onset. Although joint contractures, skin hyperpigmentation, and lesions occur with the milder phenotype, the presentation is variable, the pain is less severe, the disability may be less pronounced, and affected individuals may live into adulthood. Pain may lessen with age. Short stature, limb shortening, and brachydactyly may be present. Intractable diarrhea is rare in milder forms of the disorder.</p>
          <p>At least two individuals clinically diagnosed as having JHF developed squamous cell carcinoma [<xref ref-type="bibr" rid="sys-h.REF.kawasaki.2001.200">Kawasaki et al 2001</xref>, <xref ref-type="bibr" rid="sys-h.REF.shimizu.2005.650">Shimizu et al 2005</xref>]; the <italic toggle="yes">ANTXR2</italic> mutation status in these individuals is unknown.</p>
          <p>
            <bold>Other studies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>MRI of the brain is unremarkable.</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination does not reveal any characteristic findings and can be used to differentiate inherited systemic hyalinosis from some lysosomal storage disorders.</p>
            </list-item>
            <list-item>
              <p>Myopathic changes on muscle biopsy may be evident [<xref ref-type="bibr" rid="sys-h.REF.zolkipli.2003.401">Zolkipli et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Laboratory studies may demonstrate a normal or slightly elevated ESR, anemia, and/or thrombocytosis.</p>
            </list-item>
            <list-item>
              <p>Immunoglobulin levels may be low and cellular immune responses depressed.</p>
            </list-item>
            <list-item>
              <p>CD3 and CD4 lymphocyte subsets and ANA are unremarkable.</p>
            </list-item>
          </list>
          <p><bold>Pathology.</bold> Only a few post-mortem examinations have been reported. Hyaline deposition has been documented in the dermis, the small and large intestine, skeletal muscle, lymph nodes, thymus, spleen, thyroid, adrenals, and myocardium. Interstitial parenchymal fibrosis of the pancreas, skeletal muscle, lung, and liver was observed [<xref ref-type="bibr" rid="sys-h.REF.criado.2004.282">Criado et al 2004</xref>].</p>
        </sec>
        <sec id="sys-h.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><xref ref-type="bibr" rid="sys-h.REF.hanks.2003.791">Hanks et al [2003]</xref> reported on genotype/phenotype correlations in 17 families with features of either infantile systemic hyalinosis or JHF:</p>
          <list list-type="bullet">
            <list-item>
              <p>Those with at least one insertion/deletion in <italic toggle="yes">ANTXR2</italic> resulting in a translational frameshift had a severe phenotype (infantile systemic hyalinosis).</p>
            </list-item>
            <list-item>
              <p>All individuals with pathogenic variants situated in the von Willebrand domain had infantile systemic hyalinosis, suggesting that disruption of the protein-binding domain leads to serious clinical consequences.</p>
            </list-item>
            <list-item>
              <p>In-frame and missense variants in the cytoplasmic domain were associated with a milder phenotype, with survival to adulthood without recurrent infections, diarrhea, or multiorgan failure. Skeletal manifestations, however, were variably present.</p>
            </list-item>
          </list>
        </sec>
        <sec id="sys-h.Nomenclature">
          <title>Nomenclature</title>
          <p>Before the molecular basis of inherited systemic hyalinosis was understood, severe and milder forms of the disorder were described as separate conditions (infantile systemic hyalinosis and juvenile hyaline fibromatosis, respectively). Recent data indicate that both severe and mild forms of inherited systemic hyalinosis are caused by pathogenic variants in <italic toggle="yes">ANTXR2</italic>.</p>
        </sec>
        <sec id="sys-h.Prevalence">
          <title>Prevalence</title>
          <p>Inherited systemic hyalinosis is rare, but it has been recognized in families of various ethnic backgrounds on multiple continents [<xref ref-type="bibr" rid="sys-h.REF.felix.2004.231">Felix et al 2004</xref>]. One report described multiple cases in the Arab population [<xref ref-type="bibr" rid="sys-h.REF.almayouf.2005.717">Al-Mayouf et al 2005</xref>], reflecting the presence of consanguinity.</p>
        </sec>
      </sec>
      <sec id="sys-h.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">ANTXR2</italic>.</p>
      </sec>
      <sec id="sys-h.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The following conditions exhibit some features similar to inherited systemic hyalinosis; however, inherited systemic hyalinosis can be distinguished by the characteristic associated pain, hyperpigmented skin lesions, and perianal and perioral masses:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Farber disease (Farber lipogranulomatosis)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/228000">OMIM</ext-link>) is a lysosomal storage disease caused by deficiency of the enzyme acid ceramidase. Affected individuals typically present with painful joint contractures and progressive hoarseness. Skin nodules develop, especially over bony prominences. However, most of the reported cases have neurologic involvement, which helps distinguish Farber disease from inherited systemic hyalinosis. Furthermore, individuals with Farber disease do not have the hyperpigmented patches seen in inherited systemic hyalinosis. The diagnosis of Farber disease can be made by assessing activity of the enzyme ceramidase in fibroblasts.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ml2" document-type="chapter"><bold>I-cell disease</bold></related-object>
<bold>(mucolipidosis II)</bold> is a storage disorder associated with ineffective transport of enzymes into the lysosome accompanying a defect in the enzyme lysosomal phosphotransferase. Affected individuals develop gingival thickening and dysostosis multiplex. The facies are coarse and joint contractures develop over time. The distinctive skin findings of inherited systemic hyalinosis can help differentiate these disorders. Diagnosis is confirmed by enzyme analysis.</p>
          </list-item>
          <list-item>
            <p><bold>Non-accidental trauma.</bold> Periosteal reaction or fractures on skeletal radiographs in systemic hyalinosis have been mistaken for non-accidental trauma. The hyperpigmented skin lesions may mistakenly be considered post-traumatic, and the perianal masses can resemble condylomata, prompting a workup for an infectious etiology.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ml3a" document-type="chapter"><bold>Pseudo-Hurler polydystrophy</bold></related-object>
<bold>(mucolipidosis IIIA)</bold> is caused by pathogenic variants in <italic toggle="yes">GNPTAB</italic>, the gene encoding N-acetylglucosamine-1-phophotransferase. The phenotype varies in severity; principal features include contractures and dysostosis multiplex. The skin findings of systemic hyalinosis distinguish the two conditions.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mona" document-type="chapter"><bold>Multicentric osteolysis nodulosis and arthropathy</bold></related-object>
<bold>(MONA)</bold> is characterized by short stature and osteolysis of the interphalangeal and metacarpal-phalangeal joints. MONA lacks the distinctive dermatologic features of inherited systemic hyalinosis. Note: In addition to MONA, this phenotype has been reported in the literature as Torg syndrome, Winchester-Torg (or Torg-Winchester) syndrome, and nodulosis-arthropathy-osteolysis (NAO) syndrome. All of these conditions have been shown to be caused by biallelic pathogenic variants in <italic toggle="yes">MMP2</italic> with no discernible genotype-phenotype correlation.</p>
          </list-item>
          <list-item>
            <p><bold>Congenital generalized fibromatosis (infantile myofibromatosis)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/228550">OMIM</ext-link>) is associated with solitary, multiple, or generalized nodules composed of cells with features of differentiated fibroblasts and smooth muscle cells. Autosomal dominant inheritance has been suggested [<xref ref-type="bibr" rid="sys-h.REF.zand.2004.261">Zand et al 2004</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Stiff skin syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/184900">OMIM</ext-link>) is characterized by thickened skin and flexion contractures, with early lethality in some cases. Mucopolysaccharide deposition has been found in the skin but mucopolysacchariduria has not been detected.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="lipoid-p" document-type="chapter"><bold>Lipoid proteinosis of Urbach and Wiethe</bold></related-object>
<bold>(hyaline cutis et mucosae)</bold> presents with hoarseness, followed by the development of papules around the eyelids. Other findings include facial papules, tongue enlargement, dental hypoplasia, and skin lesions (vesicles and crusted bullae evolving into waxy plaques) that are distinct from those in inherited systemic hyalinosis. Many cases have been reported from South Africa. Pathogenic variants in <italic toggle="yes">ECM1</italic>, the gene encoding extracellular matrix protein 1, have been identified in some affected individuals.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="caffey" document-type="chapter"><bold>Caffey disease</bold></related-object>
<bold>(infantile cortical hyperostosis)</bold> presents with irritability, poor feeding, fever, and soft tissue swelling. Radiographic hyperostoses are characteristic and can help differentiate Caffey disease from inherited systemic hyalinosis. Some individuals exhibit pathogenic variants in <italic toggle="yes">COL1A1</italic>, the gene encoding collagen alpha-1(I) chain.</p>
          </list-item>
        </list>
      </sec>
      <sec id="sys-h.Management">
        <title>Management</title>
        <sec id="sys-h.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with inherited systemic hyalinosis, the following evaluations should be considered:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete nutritional evaluation, including evaluation for intestinal malabsorption</p>
            </list-item>
            <list-item>
              <p>Evaluation for immune deficiency</p>
            </list-item>
            <list-item>
              <p>Because hyalinosis of the heart has been reported, consideration of echocardiogram</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="sys-h.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>
            <bold>Pain</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Nonsteroidal anti-inflammatory drugs (NSAIDs) and opiates help control pain. Agents such as gabapentin should be considered.</p>
            </list-item>
            <list-item>
              <p>Gentle handling may reduce pain that is worsened with movement. Splinting of affected joints may provide comfort.</p>
            </list-item>
            <list-item>
              <p>When passive movement of joint contractures is painful, physiotherapy should be carried out with care; in some cases physiotherapy is not tolerated because of pain.</p>
            </list-item>
            <list-item>
              <p>Consultation with a pain management specialist may be helpful. Palliative care may be an option in severe cases.</p>
            </list-item>
          </list>
          <p>
            <bold>Failure to thrive</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Early consideration should be given to nasogastric tube or gastrostomy tube feeding.</p>
            </list-item>
            <list-item>
              <p>Nutrition should be tailored for the possibility for malabsorption or lymphangiectasia.</p>
            </list-item>
            <list-item>
              <p>A nutritionist should follow affected individuals.</p>
            </list-item>
          </list>
          <p>
            <bold>Protein-losing enteropathy</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Chronic diarrhea and protein-losing enteropathy with subsequent edema are treated with hydration and albumin infusions; an effective long-term treatment is lacking.</p>
            </list-item>
            <list-item>
              <p>The effectiveness of dietary therapies with intestinal lymphangiectasia is not known.</p>
            </list-item>
          </list>
          <p><bold>Skin nodules, gingival thickening, and lesions of the mouth.</bold> Lesions that obstruct the airway or interfere with oral intake are particularly problematic; surgical excision is an option that has been used, but lesions may recur.</p>
          <p><bold>Dermatitis.</bold> Intertriginous, perianal, and neck areas appear to be particularly prone to dermatitis and should be treated appropriately.</p>
          <p><bold>Perianal masses</bold> may be excised, but may recur.</p>
          <p><bold>Joint contractures.</bold> Contractures are typically progressive. Treatment of contractures with physiotherapy should be performed with care because of pain.</p>
          <p>
            <bold>Immune system/Infections</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Infections are treated based on the site of infection and causative agent.</p>
            </list-item>
            <list-item>
              <p>An immunology evaluation should be considered given the possibility of impaired cellular immune responses and immunoglobulin levels [<xref ref-type="bibr" rid="sys-h.REF.klebanova.2009.127">Klebanova &#x00026; Schwindt 2009</xref>].</p>
            </list-item>
          </list>
          <p><bold>Other.</bold> Given the chronic nature of this disorder in an individual with normal intelligence, family counseling should be considered in order to develop coping strategies for both the patient and the immediate family.</p>
        </sec>
        <sec id="sys-h.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Anesthesiologists should be aware of the diagnosis given the difficulty of endotracheal intubation and management in some affected individuals as a result of anatomy and gingival thickening [<xref ref-type="bibr" rid="sys-h.REF.pollard.2008.1123">Pollard et al 2008</xref>, <xref ref-type="bibr" rid="sys-h.REF.qasem.2012.263">Qasem et al 2012</xref>]. Significant complication with anesthesia has been reported [<xref ref-type="bibr" rid="sys-h.REF.elkamah.2009.6">El-Kamah &#x00026; Mostafa 2009</xref>].</p>
        </sec>
        <sec id="sys-h.Surveillance">
          <title>Surveillance</title>
          <p>Routine nutritional assessment is appropriate.</p>
          <p>Periodic assessment for gastrointestinal malabsorption may aid in optimizing nutritional status.</p>
        </sec>
        <sec id="sys-h.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The role of surgery in management of lesions is unclear since lesions appear to recur.</p>
        </sec>
        <sec id="sys-h.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="sys-h.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sys-h.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="sys-h.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sys-h.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Systemic hyalinosis is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="sys-h.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry one mutated allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being unaffected and a carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with systemic hyalinosis are obligate heterozygotes (carriers) for a pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="sys-h.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p>
        </sec>
        <sec id="sys-h.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sys-h.Prenatal_Testing_and_Premimplantat">
          <title>Prenatal Testing and Premimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible options.</p>
          <p><bold>Ultrasound examination/imaging.</bold> The utility of prenatal ultrasound examination is unclear; however, in a pregnancy at risk, detection of decreased fetal activity and contractures could suggest recurrence.</p>
        </sec>
      </sec>
      <sec id="sys-h.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sys-h.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> At least two transcripts are annotated for <italic toggle="yes">ANTXR2</italic>. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="sys-h" object-id="sys-h.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> Several pathogenic variants have been reported representing a variety of ethnic groups [<xref ref-type="bibr" rid="sys-h.REF.dowling.2003.957">Dowling et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.hanks.2003.791">Hanks et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.elkamah.2010.213">El-Kamah et al 2010</xref>, <xref ref-type="bibr" rid="sys-h.REF.denadai.2012.732">Denadai et al 2012</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>The milder phenotype, consistent with a diagnosis of juvenile hyaline fibromatosis, is more likely caused by pathogenic variants in the cytoplasmic domain (in-frame and missense) [<xref ref-type="bibr" rid="sys-h.REF.hanks.2003.791">Hanks et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p>The more severe phenotype, consistent with early onset and death in infancy or early childhood, is more likely to be caused by missense and truncating variants in the extracellular domain, although truncating variants in the transmembrane and cytoplasmic domains may also result in the severe phenotype.</p>
          </list-item>
          <list-item>
            <p>Homozygous and compound heterozygous pathogenic variants have been reported [<xref ref-type="bibr" rid="sys-h.REF.dowling.2003.957">Dowling et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.hanks.2003.791">Hanks et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.elkamah.2010.213">El-Kamah et al 2010</xref>, <xref ref-type="bibr" rid="sys-h.REF.denadai.2012.732">Denadai et al 2012</xref>].</p>
          </list-item>
        </list>
        <p>Multiple affected individuals have had pathogenic variants involving the polycytosine tract in the region encoding the cytoplasmic domain, suggesting that this may be a hot spot for mutation.</p>
        <p>Large intragenic multiexon insertion and deletion in <italic toggle="yes">ANTXR2</italic> have been reported [<xref ref-type="bibr" rid="sys-h.REF.shieh.2006.e1485">Shieh et al 2006</xref>, <xref ref-type="bibr" rid="sys-h.REF.denadai.2012.732">Denadai et al 2012</xref>].</p>
        <p><bold>Normal gene product.</bold> Anthrax toxin receptor 2 is a protein of 488 amino acids including a cytoplasmic, transmembrane, and extracellular domain. The extracellular latter domain contains a von Willebrand factor type A domain. ANTXR2 is expressed in numerous tissues including heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon, and leukocytes. It is minimally or not expressed in the brain. It is induced during capillary morphogenesis and binds laminin and collagen IV via the von Willebrand domain. It is hypothesized that anthrax toxin receptor 2 plays an important role in basement membrane matrix homeostasis. Anthrax toxin receptor 2 has significant homology to tumor endothelium marker 8 (TEM8), which also acts as an anthrax receptor [<xref ref-type="bibr" rid="sys-h.REF.scobie.2003.5170">Scobie et al 2003</xref>]. ANTXR2 knockout mice had impaired parturition and myometrial histologic changes [<xref ref-type="bibr" rid="sys-h.REF.peters.2012.393">Peters et al 2012</xref>]</p>
        <p><bold>Abnormal gene product.</bold> Abnormalities in the anthrax toxin receptor 2 protein affect anthrax toxin receptor 2-laminin interaction, likely affecting basement membrane homeostasis [<xref ref-type="bibr" rid="sys-h.REF.dowling.2003.957">Dowling et al 2003</xref>, <xref ref-type="bibr" rid="sys-h.REF.hanks.2003.791">Hanks et al 2003</xref>]. Abnormal protein may be retained in the endoplasmic reticulum [<xref ref-type="bibr" rid="sys-h.REF.deuquet.2011.208">Deuquet et al 2011</xref>], and cellular studies using proteasome inhibitors are underway.</p>
      </sec>
      <sec id="sys-h.References">
        <title>References</title>
        <sec id="sys-h.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sys-h.Literature_Cited.reflist0">
            <ref id="sys-h.REF.almayouf.2005.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Mayouf</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>AlMehaidib</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahabri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shabib</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakati</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teebi</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Infantile systemic hyalinosis: a fatal disorder commonly diagnosed among Arabs.</article-title>
                <source>Clin Exp Rheumatol</source>
                <volume>23</volume>
                <fpage>717</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16173255</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.arbour.2001">
              <mixed-citation publication-type="confproc">Arbour L, Reilly C, McGillivray B, Prendiville J, Dimmick J. Infantile systemic hyalinosis: A rare syndrome of progressive, painful contractures with peculiar hyperpigmentation and death in infancy. Greenwood, SC: Proceedings of the Greenwood Genetic Center; 2001.</mixed-citation>
            </ref>
            <ref id="sys-h.REF.criado.2004.282">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Criado</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Meneses</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ca&#x000f1;adas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rafel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanes</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Terreros</surname>
                    <given-names>IG</given-names>
                  </name>
                </person-group>
                <article-title>Infantile systemic hyalinosis: a clinicopathological study.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>129A</volume>
                <fpage>282</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15326628</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.denadai.2012.732">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Denadai</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raposo-Amaral</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertola</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stelini</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buzzo</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raposo-Amaral</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <article-title>Identification of 2 novel ANTXR2 mutations in patients with hyaline fibromatosis syndrome and proposal of a modified grading system.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>732</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">22383261</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.deuquet.2011.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deuquet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lausch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guex</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrami</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lakkaraju</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martignetti</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rokicki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonafe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Goot</surname>
                    <given-names>FG</given-names>
                  </name>
                </person-group>
                <article-title>Hyaline fibromatosis syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors.</article-title>
                <source>EMBO Mol Med.</source>
                <year>2011</year>
                <volume>3</volume>
                <fpage>208</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">21328543</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.dowling.2003.957">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Difeo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tukel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narla</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonafe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel-Apak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paller</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teebi</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grum-Tokars</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glucksman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martignetti</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.</article-title>
                <source>Am J Hum Genet</source>
                <volume>73</volume>
                <fpage>957</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">12973667</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.elkamah.2010.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>El-Kamah</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fong</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Ruby</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afifi</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clements</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai-Cheong</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amr</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Darouti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Spectrum of mutations in the ANTXR2 (CMG2) gene in infantile systemic hyalinosis and juvenile hyaline fibromatosis.</article-title>
                <source>Br J Dermatol.</source>
                <year>2010</year>
                <volume>163</volume>
                <fpage>213</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20331448</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.elkamah.2009.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>El-Kamah</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mostafa</surname>
                    <given-names>MI</given-names>
                  </name>
                </person-group>
                <article-title>Heterogeneity and atypical presentation in infantile systemic hyalinosis with severe labio-gingival enlargement: first Egyptian report.</article-title>
                <source>Dermatol Online J.</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>6</fpage>
                <pub-id pub-id-type="pmid">19624984</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.felix.2004.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Felix</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puga</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cestari</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cartell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerski</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Infantile Systemic Hyalinosis: report of three unrelated Brazilian children and review of the literature.</article-title>
                <source>Clin Dysmorphol</source>
                <volume>13</volume>
                <fpage>231</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15365459</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.hanks.2003.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbour</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balci</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bode</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keser</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teare</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Futreal</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis.</article-title>
                <source>Am J Hum Genet</source>
                <volume>73</volume>
                <fpage>791</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">14508707</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.kawasaki.2001.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kawasaki</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Juvenile hyaline fibromatosis complicated with oral squamous cell carcinoma: a case report.</article-title>
                <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
                <volume>91</volume>
                <fpage>200</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11174598</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.klebanova.2009.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klebanova</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwindt</surname>
                    <given-names>C.</given-names>
                  </name>
                </person-group>
                <article-title>Infantile Systemic Hyalinosis: A Case Report of Compromised Cellular and Humoral Branches of the Immune System Leading to Infections.</article-title>
                <source>Pediatr Asthma Allergy Immunol.</source>
                <year>2009</year>
                <volume>22</volume>
                <fpage>127</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">20563226</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.mancini.1999.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojanov</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huijmans</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Klerk</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuzevski</surname>
                    <given-names>VD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oranje</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Juvenile hyaline fibromatosis: clinical heterogeneity in three patients.</article-title>
                <source>Dermatology</source>
                <volume>198</volume>
                <fpage>18</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">10026396</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.nischal.2004.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nischal</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachdev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kharkar</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahajan</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Juvenile hyaline fibromatosis.</article-title>
                <source>J Postgrad Med</source>
                <volume>50</volume>
                <fpage>125</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15235211</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.nofal.2009.695">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nofal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assaf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nofal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nassar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almokadem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attwa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmosalamy</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile hyaline fibromatosis and infantile systemic hyalinosis: a unifying term and a proposed grading system.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2009</year>
                <volume>61</volume>
                <fpage>695</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">19344977</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.peters.2012.393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molinolo</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller-Randolph</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szabo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugge</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppla</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Capillary morphogenesis protein-2 is required for mouse parturition by maintaining uterine collagen homeostasis.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>2012</year>
                <volume>422</volume>
                <fpage>393</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22575514</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.pollard.2008.1123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pollard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ollite</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>The anesthetic management of a child with infantile systemic hyalinosis.</article-title>
                <source>Paediatr Anaesth.</source>
                <year>2008</year>
                <volume>18</volume>
                <fpage>1123</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18673317</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.qasem.2012.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qasem</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abotaiban</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Airway Management in a Patient with Infantile Systemic Hyalinosis.</article-title>
                <source>J Anesth Clin Res</source>
                <volume>3</volume>
                <fpage>263</fpage>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.rahman.2002.975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunstan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teare</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edkins</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bignell</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keser</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbour</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Futreal</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The gene for juvenile hyaline fibromatosis maps to chromosome 4q21.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>975</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">12214284</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.scobie.2003.5170">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scobie</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rainey</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>100</volume>
                <fpage>5170</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12700348</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.shieh.2006.e1485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shieh</surname>
                    <given-names>JTC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swidler</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martignetti</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balboni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdul-Rahman</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandborg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slavotinek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyme</surname>
                    <given-names>HE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Systemic hyalinosis: a distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTXR2).</article-title>
                <source>Pediatrics</source>
                <volume>118</volume>
                <fpage>e1485</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17043134</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.shimizu.2005.650">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamasaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murota</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katayama</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A case of bullous pemphigoid arising in juvenile hyaline fibromatosis with oral squamous cell carcinoma.</article-title>
                <source>J Dermatol</source>
                <volume>32</volume>
                <fpage>650</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16334866</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.stucki.2001.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spycher</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacher</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Infantile systemic hyalinosis in siblings: clinical report, biochemical and ultrastructural findings, and review of the literature.</article-title>
                <source>Am J Med Genet</source>
                <volume>100</volume>
                <fpage>122</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11298373</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.urbina.2004.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urbina</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sazunic</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Infantile systemic hyalinosis or juvenile hyaline fibromatosis?</article-title>
                <source>Pediatr Dermatol</source>
                <volume>21</volume>
                <fpage>154</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15078358</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.zand.2004.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zand</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huff</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Everman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald-McGinn</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant inheritance of infantile myofibromatosis.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>126A</volume>
                <fpage>261</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15054839</pub-id>
              </element-citation>
            </ref>
            <ref id="sys-h.REF.zolkipli.2003.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zolkipli</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holder</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Skeletal muscle involvement in infantile systemic hyalinosis.</article-title>
                <source>Eur J Paediatr Neurol</source>
                <volume>7</volume>
                <fpage>401</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14623219</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sys-h.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sys-h.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 April 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 February 2008 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 May 2004 (la) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
